Oxygen Biotherapeutics, Inc. Logo
Oxygen Biotherapeutics Receives U.S. Army Grant for Studies of Oxycyte(R), a Novel Traumatic Brain Injury Therapeutic for Combat Casualties
March 02, 2011 02:00 ET | Oxygen Biotherapeutics, Inc.
MORRISVILLE, N.C., March 2, 2011 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT) today announced it has received a $2.075 million, two-year grant from the U.S....
Oxygen Biotherapeutics, Inc. Logo
Oxygen Biotherapeutics Awarded $244,479 Grant Under the Patient Protection and Affordable Care Program
November 02, 2010 02:00 ET | Oxygen Biotherapeutics, Inc.
DURHAM, N.C., Nov. 2, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT) today announced it has received nearly $245,000 in a grant under the Patient...